Two local diagnostic companies in recent weeks announced deals to further develop tests to detect cancers.
Hollywood Hills West-based Topography Health Inc., which has a program to help community physicians set up clinical trials, announced its official launch on Jan. 19 after raising $21.5 million in a Series A funding round.
Beverly Hills-based biotechnology company Capricor Therapeutics Inc. announced on Jan. 25 a major commercialization and distribution deal with a Japanese pharmaceutical company for its drug to treat the rare degenerative genetic disease Duchene muscular dystrophy.
Just two years ago, Temple City-based Fulgent Genetics Inc. was a small but promising genetic testing company with $32 million in revenue for all of 2019.
After taking a hit during the initial Covid-19 lockdown, Sawtelle-based RadNet Inc., the nation’s largest operator of stand-alone diagnostic imaging centers, is revolutionizing the industry through its use of artificial intelligence and joint ventures with hospital networks.
The Santa Monica-based health tech communications platform provider received the investment from a New York-based private equity firm.
Santa Monica-based digital health startup SixD Inc., which does business as HeyRenee, announced Jan. 13 that it had closed a second round of seed funding, bringing its total amount raised to $8.2 million as it prepares to launch its senior-oriented service next quarter.
After a rough inaugural year as a publicly traded company, has ImmunityBio Inc. finally turned the corner?
Pasadena-based Arrowhead Pharmaceuticals Inc. last month announced an investment of up to $250 million for a new drug manufacturing facility outside of California.
Duarte-based Prolacta Bioscience Inc., which has been fortifying and supplying human breast milk from donors to premature and critically ill infants in hospitals across the United States since 1999, is attempting to go international for the first time.
In its largest cancer treatment acquisition to date, City of Hope announced it has agreed to purchase Cancer Treatment Centers of America.
The gift will be used to establish a scholarship fund for a master of science in community medicine degree program within the KGI School of Medicine.
In recent weeks, Culver City-based ImmunityBio Inc. has struck deals with two companies to gain access to technologies to help speed development of its Covid-19 vaccine candidate.
Westwood-based Puma Biotechnology Inc. announced Nov. 23 that it has won from U.S. regulators a five-year extension on the patent for its breast cancer therapy Nerlynx.
There’s been a generational leadership change at Alhambra-based Apollo Medical Holdings Inc.